Embecta Corp. (EMBC)
USD 11.31
(-6.45%)
USD 11.31
(-6.45%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.62 Billion USD | -0.33% |
| 2022 | 1.63 Billion USD | 54256.67% |
| 2021 | 3 Million USD | -25.0% |
| 2020 | 4 Million USD | 0.0% |
| 2019 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 1.59 Billion USD | -0.07% |
| 2024 Q1 | 1.62 Billion USD | -0.06% |
| 2024 Q3 | 1.59 Billion USD | -0.06% |
| 2023 Q1 | 1.62 Billion USD | -0.08% |
| 2023 FY | 1.62 Billion USD | -0.33% |
| 2023 Q4 | 1.62 Billion USD | -0.09% |
| 2023 Q3 | 1.62 Billion USD | -0.07% |
| 2023 Q2 | 1.62 Billion USD | -0.09% |
| 2022 Q4 | 1.63 Billion USD | -0.09% |
| 2022 Q2 | 1.6 Billion USD | 0.0% |
| 2022 FY | 1.63 Billion USD | 54256.67% |
| 2022 Q3 | 1.63 Billion USD | 1.96% |
| 2022 Q1 | - USD | -100.0% |
| 2021 Q1 | - USD | 0.0% |
| 2021 FY | 3 Million USD | -25.0% |
| 2021 Q4 | 3 Million USD | 0.0% |
| 2020 FY | 4 Million USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 309.66 Million USD | -424.883% |
| Aquestive Therapeutics, Inc. | 91.07 Million USD | -1684.663% |
| Collegium Pharmaceutical, Inc. | 489.96 Million USD | -231.74% |
| Dynavax Technologies Corporation | 252.41 Million USD | -543.932% |
| Esperion Therapeutics, Inc. | 501.54 Million USD | -224.078% |
| Cosmos Health Inc. | 3.03 Million USD | -53449.173% |
| Pacira BioSciences, Inc. | 513.79 Million USD | -216.351% |
| PainReform Ltd. | 30 Thousand USD | -5417900.0% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -301438.861% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -301438.861% |
| SCYNEXIS, Inc. | 12.15 Million USD | -13267.876% |
| Safety Shot Inc | 304.9 Thousand USD | -532980.579% |
| China SXT Pharmaceuticals, Inc. | 117.12 Thousand USD | -1387600.74% |
| Alpha Teknova, Inc. | 13.25 Million USD | -12166.244% |
| Bright Green Corporation | 201.78 Thousand USD | -805418.8% |
| Intra-Cellular Therapies, Inc. | 13.32 Million USD | -12097.208% |
| Journey Medical Corporation | 14.62 Million USD | -11016.126% |
| Procaps Group, S.A. | 28.41 Million USD | -5621.225% |
| Theratechnologies Inc. | 51.26 Million USD | -3070.832% |
| Harrow Health, Inc. | 183.17 Million USD | -787.363% |
| Sonoma Pharmaceuticals, Inc. | 87 Thousand USD | -1868175.862% |
| Biofrontera Inc. | 804 Thousand USD | -202064.179% |
| DURECT Corporation | 2.7 Million USD | -60055.44% |
| Supernus Pharmaceuticals, Inc. | 33.19 Million USD | -4796.373% |
| Cronos Group Inc. | 1.55 Million USD | -104159.14% |
| OptiNose, Inc. | 611 Thousand USD | -265922.913% |
| Ironwood Pharmaceuticals, Inc. | 498.3 Million USD | -226.183% |
| Kala Pharmaceuticals, Inc. | 34.19 Million USD | -4654.022% |
| RedHill Biopharma Ltd. | 455 Thousand USD | -357130.769% |
| Organogenesis Holdings Inc. | 60.74 Million USD | -2575.776% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| Cumberland Pharmaceuticals Inc. | 12.78 Million USD | -12614.187% |
| Radius Health, Inc. | 339.66 Million USD | -378.53% |
| Universe Pharmaceuticals INC | - USD | -Infinity% |
| ProPhase Labs, Inc. | 10.25 Million USD | -15745.194% |
| Phibro Animal Health Corporation | 458.28 Million USD | -254.667% |
| Procaps Group S.A. | 28.41 Million USD | -5621.225% |
| Alvotech | 1.02 Billion USD | -58.149% |
| TherapeuticsMD, Inc. | 6.53 Million USD | -24783.65% |
| Viatris Inc. | 16.18 Billion USD | 89.959% |
| Rockwell Medical, Inc. | 8.29 Million USD | -19499.665% |
| Aytu BioPharma, Inc. | 10.87 Million USD | -14843.459% |
| SIGA Technologies, Inc. | 335.99 Thousand USD | -483662.958% |
| Tilray Brands, Inc. | 287.93 Million USD | -464.502% |
| Lifecore Biomedical, Inc. | 120.51 Million USD | -1248.768% |
| Shineco, Inc. | 10.01 Million USD | -16125.877% |
| PetIQ, Inc. | 437.82 Million USD | -271.248% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Incannex Healthcare Limited | 210 Thousand USD | -773900.0% |
| Neurocrine Biosciences, Inc. | 258.3 Million USD | -529.268% |
| Alimera Sciences, Inc. | 64.48 Million USD | -2420.43% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 38.51 Million USD | -4120.284% |
| Shuttle Pharmaceuticals Holdings, Inc. | 135.08 Thousand USD | -1203106.775% |
| Petros Pharmaceuticals, Inc. | 6.85 Million USD | -23602.986% |
| Clever Leaves Holdings Inc. | 720 Thousand USD | -225650.0% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -7229040.722% |
| Avadel Pharmaceuticals plc | 32.75 Million USD | -4861.539% |
| Hempacco Co., Inc. | 5.93 Million USD | -27305.155% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 1.02 Billion USD | -58.149% |
| Eagle Pharmaceuticals, Inc. | 56.21 Million USD | -2791.348% |
| Lantheus Holdings, Inc. | 616.12 Million USD | -163.811% |
| Currenc Group, Inc. | 2.5 Million USD | -64735.136% |
| Kamada Ltd. | 7.43 Million USD | -21752.649% |
| Indivior PLC | 235.66 Million USD | -589.703% |
| Evoke Pharma, Inc. | 5 Million USD | -32408.0% |
| Flora Growth Corp. | 942 Thousand USD | -172447.771% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -7229040.722% |
| Evolus, Inc. | 120.35 Million USD | -1250.46% |
| HUTCHMED (China) Limited | 48.18 Million USD | -3272.969% |
| Amphastar Pharmaceuticals, Inc. | 589.19 Million USD | -175.866% |
| Akanda Corp. | 2.49 Million USD | -64990.073% |